Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
International Journal of Clinical Oncology|March 7, 2015
How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) surveyYoshihito Yokoyama, Kiyoshi Ito, Kiyoshi Takamatsu, et al.
Human Cell|October 7, 2006
Loss of integrin alpha3 expression associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cellsNao Suzuki, Atsushi Higashiguchi, Yuko Hasegawa, et al.
International Journal of Oncology|February 28, 2012
Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review)Kouji Banno, Iori Kisu, Megumi Yanokura, et al.
International Journal of Oncology|September 30, 2009
Analysis of candidate target genes for mononucleotide repeat mutation in microsatellite instability-high (MSI-H) endometrial cancerMakiko Kawaguchi, Kouji Banno, Megumi Yanokura, et al.
Oncology Letters|August 8, 2012
MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review)Megumi Yanokura, Kouji Banno, Yusuke Kobayashi, et al.
Gynecologic Oncology|September 8, 2004
A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinomaNao Suzuki, Daisuke Aoki, Shinji Oie, et al.
Reproductive Biology and Endocrinology : RB&E|January 16, 2016
Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasiaOsamu Inoue, Toshio Hamatani, Nobuyuki Susumu, et al.
Human Pathology|September 25, 2003
P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervixNobuo Masumoto, Takuma Fujii, Mitsuya Ishikawa, et al.
Cancer Science|November 10, 2025
Prognostic Biomarker of Fertility-Preserving Hormonal Therapy Based on Multigene Panel Testing for Endometrial CancerTakuro Hirano, Kensuke Sakai, Takuma Yoshimura, et al.
Cancer Science|December 17, 2017
ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell deathMari Ueno, Takayuki Shiomi, Satsuki Mochizuki, et al.
Pageof 13